Over the past decade, real-time continuous glucose monitoring (rtCGM) with subcutaneous sensors has transformed our understanding of glucose metabolism and diabetes treatment in outpatient care, and is now being considered in the hospital setting .
Screening for diabetic retinopathy (DR) is now well established in clinical practice, and in some systems it is considered a measure of adherence to best practice. The article by Silva et al. in this issue of Diabetes Care (1) investigates self awareness of DR and whether planned follow-up is concordant with national guideline recommendations.